meta_pixel
Tapesearch Logo
Log in
Habits and Hustle

Episode 129: Charles Brenner – Discovered Nicotinamide as NAD Precursor, Dept. Chair at City of Hope

Habits and Hustle

Jen Cohen and Habit Nest

Education, Health & Fitness, Business, Self-improvement, Entrepreneurship

4.4763 Ratings

🗓️ 17 August 2021

⏱️ 75 minutes

🧾️ Download transcript

Summary

Charles Brenner discovered Nicotinamide Riboside as a NAD Precursor and is the Alfred E Mann Family Foundation Chair in Diabetes and Cancer Metabolism at City of Hope National Medical Center. A “scientists’ scientist” Charles isn’t afraid to ruffle feathers in the defense of scientific truths. If it doesn’t have scientific backing in a legitimate peer-reviewed essay with double-blind studies and placebos Charles doesn’t want to hear about it. He explains his own scientific breakthroughs, the possible future for his work, and a bit of the new studies that have recently come out on the subject, while also answering Jen’s questions about the latest fads that may or may not have any scientific backing. Intermittent fasting, “calories in; calories out,” longevity, and more. Charles is the real deal. You won’t find him caving to the pressures of what’s “in” at the moment or who might be paying off who. He’s here for the science and science alone, and I hope you’re ready, cuz that’s exactly what this episode’s about. Youtube Link to This Episode Charles Brenner’s Twitter – https://twitter.com/charlesmbrenner Charles Brenner’s Instagram – https://www.instagram.com/charlesmbrenner/ ⭐⭐⭐⭐⭐ Did you learn something from tuning in today? Please pay it forward and write us a 5-star review on Apple Podcasts. 📧If you have feedback for the show, please email [email protected] 📙Get yourself a copy of Jennifer Cohen’s newest book from Habit Nest, Badass Body Goals Journal. ℹ️Habits & Hustle Website 📚Habit Nest Website 📱Follow Jennifer – Instagram – Facebook – Twitter – Jennifer’s Website Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

Crypto doesn't sleep, so neither do we.

0:04.0

Crack-in client support is available 24-7, 365 days a year by call, chat, or email.

0:11.0

We're here for you whenever you need us.

0:13.0

Give us a shout at crackin.com forward slash support proof,

0:17.0

not investment advice. Crypto trading involves risk of loss.

0:23.0

Hi guys, it's Tony Robbins. You're listening to Habits in Hustle.

0:27.0

Pressure.

0:33.0

On Habits in Hustle today, we have Dr. Charles Brenner.

0:36.0

Dr. Brenner is one of the world's foremost authorities in the emerging area of NAD.

0:41.0

NAD is a molecule that is critical to the healthy function of the trillions of cells in our bodies.

0:48.0

He serves as the Alfred E. Mann family foundation chair in the newly created department of diabetes

0:54.0

and cancer metabolism at the city of Hope.

0:57.0

He is also the chief scientific advisor to Chromodex, a global bioscience company

1:02.0

behind the popular NAD boosting supplement called True Niantion,

1:06.0

which of course, I'm a huge fan of and talk about all the time.

1:10.0

Among his most significant discoveries in 2004, he identified nicotinamide riboside,

1:18.0

otherwise known as NR.

1:21.0

As a precursor or a booster of NAD levels, his pioneering research has paved the way for NAD research around the world.

1:29.0

So without further ado, here is Dr. Charles Brenner.

1:35.0

So let's just go from the beginning.

1:37.0

So what is, I mean, I've been a huge fan of NAD.

1:41.0

I've been taking True Niantion for two years at least.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Jen Cohen and Habit Nest, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Jen Cohen and Habit Nest and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.